These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 21701927)
1. Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial. Katz MH; Wolff R; Crane CH; Varadhachary G; Javle M; Lin E; Evans DB; Lee JE; Fleming JB; Pisters PW Ann Surg Oncol; 2011 Dec; 18(13):3615-22. PubMed ID: 21701927 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial. Reni M; Balzano G; Aprile G; Cereda S; Passoni P; Zerbi A; Tronconi MC; Milandri C; Saletti P; Rognone A; Fugazza C; Magli A; Di Muzio N; Di Carlo V; Villa E Ann Surg Oncol; 2012 Jul; 19(7):2256-63. PubMed ID: 22237835 [TBL] [Abstract][Full Text] [Related]
5. Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Picozzi VJ; Abrams RA; Decker PA; Traverso W; O'Reilly EM; Greeno E; Martin RC; Wilfong LS; Rothenberg ML; Posner MC; Pisters PW; Ann Oncol; 2011 Feb; 22(2):348-54. PubMed ID: 20670978 [TBL] [Abstract][Full Text] [Related]
6. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Picozzi VJ; Kozarek RA; Traverso LW Am J Surg; 2003 May; 185(5):476-80. PubMed ID: 12727570 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: a single-institution phase II study. Linehan DC; Tan MC; Strasberg SM; Drebin JA; Hawkins WG; Picus J; Myerson RJ; Malyapa RS; Hull M; Trinkaus K; Tan BR Ann Surg; 2008 Aug; 248(2):145-51. PubMed ID: 18650621 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. You DD; Lee HG; Heo JS; Choi SH; Choi DW J Gastrointest Surg; 2009 Sep; 13(9):1699-706. PubMed ID: 19582512 [TBL] [Abstract][Full Text] [Related]
9. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma. Schmidt J; Abel U; Debus J; Harig S; Hoffmann K; Herrmann T; Bartsch D; Klein J; Mansmann U; Jäger D; Capussotti L; Kunz R; Büchler MW J Clin Oncol; 2012 Nov; 30(33):4077-83. PubMed ID: 23008325 [TBL] [Abstract][Full Text] [Related]
10. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759]. Knaebel HP; Märten A; Schmidt J; Hoffmann K; Seiler C; Lindel K; Schmitz-Winnenthal H; Fritz S; Herrmann T; Goldschmidt H; Krempien R; Mansmann U; Debus J; Diehl V; Büchler MW BMC Cancer; 2005 Apr; 5():37. PubMed ID: 15826316 [TBL] [Abstract][Full Text] [Related]
11. Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. Ohman KA; Liu J; Linehan DC; Tan MC; Tan BR; Fields RC; Strasberg SM; Hawkins WG HPB (Oxford); 2017 May; 19(5):449-457. PubMed ID: 28162923 [TBL] [Abstract][Full Text] [Related]
12. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma. Hattangadi JA; Hong TS; Yeap BY; Mamon HJ Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088 [TBL] [Abstract][Full Text] [Related]